Cargando…
Allogeneic cell-based immunotherapy combined with chemotherapy and targeted therapy in advanced pancreatic cancer with metastases: A case report
Immunotherapy may be an effective and potentially less toxic treatment for cancer in addition to the traditional therapies. The current study presents a case of advanced pancreatic cancer that was treated with cell-based immunotherapy using expanded activated allogeneic lymphocytes (EAAL(*)) in vitr...
Autores principales: | LONG, YANYAN, SUN, QIONG, WU, JIANYU, WANG, YU, JIAO, SHUNCHANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997695/ https://www.ncbi.nlm.nih.gov/pubmed/24765183 http://dx.doi.org/10.3892/ol.2014.1908 |
Ejemplares similares
-
Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy
por: Fomchenko, Elena I., et al.
Publicado: (2022) -
Advances in the Treatment of Spinal Metastasis: Commentary on “Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy”
por: Bergin, Stephen, et al.
Publicado: (2022) -
Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
por: Wilmott, James S., et al.
Publicado: (2012) -
Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases
por: Rutkowski, Piotr, et al.
Publicado: (2023) -
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
por: Golan, Talia, et al.
Publicado: (2015)